Neurocrine Biosciences Inc

Erste Asset Management GmbH NBIX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/11/2026

Shares

19,700

Value ($000)

2,830

Weight

0.0%

2018 Q4 - 2025 Q4 (29 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/11/2026	2,830	0.0%	19,700	12/31/2025
2025 Q3	11/12/2025	3,338	0.0%	23,800	9/30/2025
2025 Q2	8/14/2025	3,349	0.0%	26,700	6/30/2025
2025 Q1	5/14/2025	2,693	0.0%	23,800	3/31/2025
2024 Q4	2/10/2025	3,319	0.0%	23,800	12/31/2024
2024 Q3	11/14/2024	2,738	0.0%	23,800	9/30/2024
2024 Q2	11/26/2024	3,197	0.0%	23,800	6/30/2024
2024 Q1	11/26/2024	3,280	0.0%	23,800	3/31/2024
2023 Q4	11/26/2024	3,145	0.0%	23,800	12/31/2023
2023 Q3	11/26/2024	2,741	0.0%	23,800	9/30/2023
2023 Q2	11/26/2024	2,249	0.0%	23,800	6/30/2023
2023 Q1	11/26/2024	2,361	0.0%	23,800	3/31/2023
2022 Q4	11/26/2024	2,861	0.1%	23,800	12/31/2022
2022 Q3	11/26/2024	2,446	0.1%	23,800	9/30/2022
2022 Q2	11/26/2024	2,343	0.1%	23,800	6/30/2022
2022 Q1	11/25/2024	2,200	0.0%	23,800	3/31/2022
2021 Q4	11/25/2024	2,098	0.0%	24,900	12/31/2021
2021 Q3	11/25/2024	2,350	0.0%	24,900	9/30/2021
2021 Q2	11/25/2024	2,414	0.0%	24,900	6/30/2021
2021 Q1	11/25/2024	2,347	0.1%	24,900	3/31/2021
2020 Q4	11/25/2024	2,341	0.1%	24,900	12/31/2020
2020 Q3	11/25/2024	3,879	0.1%	39,700	9/30/2020
2020 Q2	11/22/2024	4,982	0.2%	39,700	6/30/2020
2020 Q1	11/22/2024	3,636	0.2%	39,700	3/31/2020
2019 Q4	11/22/2024	12,342	0.5%	114,700	12/31/2019
2019 Q3	11/22/2024	8,716	0.5%	96,700	9/30/2019
2019 Q2	11/22/2024	8,759	0.5%	104,700	6/30/2019
2019 Q1	11/22/2024	9,211	0.5%	105,700	3/31/2019
2018 Q4	11/26/2024	8,443	0.6%	120,900	12/31/2018